Among DC subsets, CD103+ conventional type 1 dendritic cells (cDC1s) are uniquely equipped for antigen cross-presentation, a process by which exogenous tumor-derived antigens are processed and presented on MHC class I molecules (46, 47). Here, ITGAE is linked to neoplasm.